Ogasawara et al. reported that Evo has remarkable inhibitory activity against hepatocyte growth factor (HGF)-induced migration of tumor cells (colon 26-L5 carcinoma, B16-F10 melanoma and Lewis lung carcinoma) [21–33]. This evidence concerns the gene HGF and Carcinoma, Lewis Lung.